focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksExperian Regulatory News (EXPN)

Share Price Information for Experian (EXPN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3,741.00
Bid: 3,742.00
Ask: 3,745.00
Change: -6.00 (-0.16%)
Spread: 3.00 (0.08%)
Open: 3,742.00
High: 3,755.00
Low: 3,736.00
Prev. Close: 3,747.00
EXPN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Experian Q3 FY23 trading update

17 Jan 2023 07:00

RNS Number : 8792M
Experian plc
17 January 2023
 

news release

 

 

Trading update, third quarter

 

 

17 January 2023 ─ Experian plc, the global information services company, today issues an update on trading for the three months ended 31 December 2022.

 

Brian Cassin, Chief Executive Officer, commented:

 

"We delivered a good performance in Q3, in line with our expectations, driven by new products, new business wins and consumer expansion. At constant exchange rates, organic revenue growth was 6% and total revenue growth was 7%. After the impact of foreign exchange rates total revenue growth was 4%.

 

"While pressures in the global economy are likely to continue for some time, we expect to remain resilient, supported by the delivery of our growth strategy and growth in countercyclical revenue streams. For the full year our expectations are unchanged, for organic revenue growth of between 7-9%, total revenue growth of between 8-10% and modest margin accretion, all at constant exchange rates and on an ongoing basis."

 

% change in revenue from ongoing activities year-on-year for the three months ended 

31 December 2022

Ongoing activities only

Total revenue growth %

Total revenue growth %

Organic revenue growth %

 

At actual

exchange rates1

At constant exchange rates

At constant exchange rates

North America

5

5

5

Latin America

21

17

16

UK and Ireland

(7)

6

6

EMEA/Asia Pacific

(10)

1

1

Total global

4

7

6

1 Experian reports in US dollars.

 

% change in organic revenue year-on-year for the three months ended 31 December 2022

Organic revenue growth %2

Data

Decisioning

B2B3

Consumer Services

Total

 

 

North America

2

5

2

9

5

Latin America

10

14

11

40

16

UK and Ireland

7

15

10

(8)

6

EMEA/Asia Pacific

(3)

16

1

n/a

1

Total global

3

9

5

10

6

2 Ongoing activities only, at constant exchange rates.

3 B2B = Business-to-Business segment which consists of Data and Decisioning business sub-divisions.

 

 

 

Business mix including % change in organic revenue year-on-year for the three months ended 31 December 2022

Segment

 

Business unit

% of Group revenue4

Q3 organic revenue growth %5

North America

68%

5%

 Data

CI / BI Bureaux

25%

(2)%

- CI / BI Bureaux, excluding mortgage

22%

5%

- Mortgage

3%

(42)%

Automotive

5%

7%

Targeting

3%

14%

 Decisioning

Health

8%

4%

DA / Other

4%

7%

 Consumer Services

Consumer Services

23%

9%

Latin America

14%

16%

 Data

CI / BI Bureaux

9%

11%

Other

0%

(3)%

 Decisioning

DA / Other

3%

14%

 Consumer Services

Consumer Services

2%

40%

UK and Ireland

12%

6%

 Data

CI / BI Bureaux

5%

7%

Targeting / Auto

1%

9%

 Decisioning

DA / Other

3%

15%

 Consumer Services

Consumer Services

3%

(8)%

EMEA/Asia Pacific

6%

1%

Total global

100%

6%

4 Percentage of Group revenue from ongoing activities calculated based on H1 FY23 revenue at actual exchange rates.

5 Ongoing activities only, at constant exchange rates.

CI = Consumer Information, BI = Business Information, DA = Decision Analytics.

 

North America - 68% of Group revenue4

 

North America delivered organic and total revenue growth of 5%.

 

B2B organic revenue growth was 2% reflecting good progress on new products, partially offset by mortgage decline and strong prior-year comparables in short term lending and health. While some clients have further tightened credit criteria, consumer and business information contributed favourably, excluding mortgage, and as we lapped last year's strong holiday season. Experian Ascend contributed strongly, securing new client wins, and we continue to make good progress across decisioning software, analytics and fraud and identity management. Verification services also performed strongly. Targeting and automotive performed well supported by new product performance and new business wins, as did health, excluding the prior-year COVID-19 related one-off item.

 

Consumer Services organic revenue growth was 9%, reflecting growth in marketplace, premium services and partner solutions. We are developing new propositions to help consumers build credit and manage their finances and we are rolling out Experian Activate to help our lender partners target credit offers more precisely. Paid enrolments performed strongly, and we are adding free members to take our free membership base to 59m.

Latin America - 14% of Group revenue4

Latin America delivered organic revenue growth of 16%. At constant currency, total revenue growth was 17%, including contributions from acquisitions in Consumer Services, and from our new bureaux in Chile and Panama.

 

B2B organic revenue growth was 11%. In Brazil, we continue to benefit from client adoption of positive data products. We have also secured new implementations for Experian Ascend, and we have strong traction with our cloud-enabled decisioning platforms. We also see growing contributions from our small and medium enterprise channel and our agribusiness vertical. Spanish Latin America delivered a strong performance as we expand our presence across the region.

 

Consumer Services delivered organic revenue growth of 40%. Free consumer memberships in Brazil rose to 78m. We delivered a very successful Limpa Nome credit fair, which helps consumers to resolve and settle bills, and our credit comparison marketplace and premium services also delivered good growth.

 

UK and Ireland - 12% of Group revenue4

 

Performance in the UK & Ireland was encouraging, delivering organic and total constant currency revenue growth of 6%, notwithstanding challenges in the economy and specific market disruption during October.

 

B2B organic revenue growth was 10%. This reflects strong results from new products and good execution across all major B2B business units, including consumer credit information, business credit information, analytics, fraud and identity management and targeting, and helped by a strong new business win performance. Most lenders continue to extend credit, having tightened criteria and reduced supply in some categories, while consumer demand for credit is generally elevated. Lender appetite is increasing for analytics to monitor affordability and to derive cost-of living insights, as well as for data and analytics to provide visibility on small business economic exposure.

 

Organic revenue in Consumer Services declined 8%, as volumes moderated in our credit marketplace, reflecting the lending market disruption in October and tighter lending conditions, as well reduced premium subscription revenue. Free memberships were 12m.

 

EMEA/Asia Pacific - 6% of Group revenue4

 

Organic revenue growth and total revenue growth at constant exchange rates across EMEA/Asia Pacific was 1%, with growth across the majority of our strategic markets. We are making good progress on our plan to strengthen and focus our EMEA/Asia Pacific operations.

 

 

Future events

 

Experian will release results for the full year ending 31 March 2023 on Wednesday, 17 May 2023.

 

Contact:

Experian

Nadia Ridout-Jamieson Investor queries +44 (0)20 3042 4200

Gerry Tschopp, Nick Jones Media queries

 

Tulchan

Graeme Wilson, Louise Male and Guy Bates +44 (0)20 7353 4200

 

This announcement is available on the Experian website at www.experianplc.com. There will be a conference call today to discuss this update at 9.00am (UK time), which will be broadcast live on the website with a recording available later.

 

All financial information in this trading update is based on unaudited management accounts. Certain statements made in this trading update are forward-looking statements. Such statements are based on current expectations and are subject to a number of risks and uncertainties that could cause actual events or results to differ materially from any expected future events or results referred to in these forward-looking statements.

 

Neither the content of the Company's website, nor the content of any website accessible from hyperlinks on the Company's website (or any other website), is incorporated into, or forms part of, this announcement.

 

About Experian

Experian is the world's leading global information services company. During life's big moments - from buying a home or a car, to sending a child to college, to growing a business by connecting with new customers - we empower consumers and our clients to manage their data with confidence. We help individuals to take financial control and access financial services, businesses to make smarter decisions and thrive, lenders to lend more responsibly, and organisations to prevent identity fraud and crime.

 

We have 21,700 people operating across 30 countries and every day we're investing in new technologies, talented people, and innovation to help all our clients maximise every opportunity. We are listed on the London Stock Exchange (EXPN) and are a constituent of the FTSE 100 Index.

 

Learn more at www.experianplc.com or visit our global content hub at our global news blog for the latest news and insights from the Group.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFLFITLDIRLIV
Date   Source Headline
17th Sep 20194:57 pmRNSTransaction in Own Shares
16th Sep 20195:03 pmRNSTransaction in Own Shares
13th Sep 20195:01 pmRNSTransaction in Own Shares
12th Sep 20195:20 pmRNSTransaction in Own Shares
11th Sep 20195:09 pmRNSTransaction in Own Shares
10th Sep 20195:10 pmRNSTransaction in Own Shares
30th Aug 201911:58 amRNSTotal Voting Rights
22nd Aug 20199:37 amRNSAdditional Listing
21st Aug 20198:00 amRNSExperian acquires Look Who's Charging
15th Aug 20195:09 pmRNSTransaction in Own Shares
8th Aug 201911:00 amRNSAcquisition of MyHealthDirect
6th Aug 20195:05 pmRNSTransaction in Own Shares
5th Aug 20195:22 pmRNSTransaction in Own Shares
1st Aug 201912:30 pmRNSDirector/PDMR Shareholding
31st Jul 201911:05 amRNSTotal Voting Rights
25th Jul 20199:30 amRNSAdditional Listing
24th Jul 201912:30 pmRNSResult of AGM
16th Jul 20197:00 amRNSTrading update, First quarter
11th Jul 20195:27 pmRNSTransaction in Own Shares
5th Jul 20195:36 pmRNSSecond Interim Dividend
28th Jun 20193:30 pmRNSShare repurchases
28th Jun 201912:46 pmRNSTotal Voting Rights
21st Jun 20194:05 pmRNSDirector/PDMR Shareholding
21st Jun 20194:00 pmRNSDirector/PDMR Shareholding
14th Jun 20192:35 pmRNSAnnual Financial Report
13th Jun 20193:56 pmRNSDirector/PDMR Shareholding
13th Jun 20199:10 amRNSAdditional Listing
10th Jun 20194:15 pmRNSDirector/PDMR Shareholding
7th Jun 201911:28 amRNSElections for second interim dividend
6th Jun 20194:22 pmRNSTransaction in Own Shares
31st May 201911:19 amRNSTotal Voting Rights
29th May 20197:00 amRNSAppointment of Chairman
15th May 20193:41 pmRNSShare repurchases
15th May 20197:00 amRNSPreliminary results for year ended 31 March 2019
1st May 20199:00 amRNSCompletion of acquisition of Compuscan
30th Apr 20193:26 pmRNSTotal Voting Rights
10th Apr 20191:17 pmRNSAdditional Listing
4th Apr 20192:38 pmRNSIrrevocable and non-discretionary arrangement
29th Mar 20192:36 pmRNSTotal Voting Rights
25th Mar 20195:08 pmRNSTransaction in Own Shares
19th Mar 20194:22 pmRNSBlock listing Interim Review
14th Mar 20195:22 pmRNSTransaction in Own Shares
12th Mar 20195:33 pmRNSTransaction in Own Shares
28th Feb 20192:38 pmRNSTotal Voting Rights
27th Feb 20197:49 amRNSAmended: Update on proposed ClearScore acquisition
27th Feb 20197:00 amRNSUpdate on proposed ClearScore acquisition
20th Feb 201911:19 amRNSAdditional Listing
25th Jan 201911:00 amRNSIssue of Notes
23rd Jan 20199:15 amRNSAdditional Listing
17th Jan 20197:00 amRNSTrading update, third quarter

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.